HIV
News
Decentralizing PrEP offers a road map for retention
News
Polypharmacy common among patients aged 65 or older with HIV
News
Counterfeit HIV drugs: Justice Department opens investigation
Clinicians are encouraged to inform HIV patients about the risks associated with counterfeit medications, how to determine whether the drugs they’...
News
MSM have higher CD4 counts at HIV diagnosis than heterosexuals
“We were stunned.”
News
Veterans Potentially Exposed to HIV, HCV at Georgia Hospital
News
Honoring Dr. Paul Farmer: Dr. Serena Koenig shares her memories of working with him
Dr. Farmer and his colleagues at Partners in Health started the HIV Equity Initiative, which was one of the first programs in the world to provide...
Conference Coverage
Full results of anal cancer study point to barriers to care
Infrastructure, algorithms, and workforce training are going be needed to meet the currently unserved people through use of high-resolution...
Conference Coverage
A third person living with HIV has been cured by transplant
“There was no GVH disease. That’s incredible. It’s a wonderful thing.”
News
FDA approves 2-month dosing of injectable HIV drug Cabenuva
“Adults living with HIV have a treatment option that further reduces the frequency of medication,” said Candice Long of Janssen Therapeutics.
News
One in 12 abandons HIV PrEP prescriptions in U.S., with cost a key barrier
People who received PrEP through a rural provider versus an urban provider were also more likely to abandon PrEP.